Synonyms: Anspor; Cefradine; Nicef; BCP9000506; CCG-208520; CS-4608; DB01333; IDI1_000739; NCGC00183036-02; NCGC00263658-01; 7beta-[(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid; AN-14970; BC205857; Non-Stoichiometric Hydrate Cephradine; SC-13473; LS-149955; FT-0603004; C06897; D00264; 821C533; Cefradine, European Pharmacopoeia (EP) Reference Standard; Cefradine for peak identification, European Pharmacopoeia (EP) Reference Standard; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6-alpha,7-beta(R*)))-; Sefril; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)-; cefradex; Maxisporin; Septacef; Kelsef; Dexef; Nicef; Zeefra Ge; Cephradine dihydrate; CEPHRADINE SODIUM; Septacef; Cephradine monohydrate; Dihydrate, Cephradine; UNII-FUC0D71IZN; D06KKS; VELOSEF 125; VELOSEF 250; VELOSEF 500; C16H19N3O4S; Cephradine(sterile/non-sterile); CID38103; SQ 11436; C16-H19-N3-O4-S; Non-Stoichiometric Hydrate Cephradine; SK&F D-39304; Cephradine, Non Stoichiometric Hydrate; Cephradine, Non-Stoichiometric Hydrate; CS-O-30547; SQ11436; C2988; D002515; (6R- -( -3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid; SQ-11436; 7-[D-2-amino-2-(1,4-cyclohexadienyl)acetamido]desacetoxycephalosporanic acid; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-, [6R-[6.alpha.,7.beta.(R*)]]-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-, monohydrate, [6R-[6.alpha.,7.beta.(R*)]]-; SQ11436; Velocef; Velosef; Zeefra Gé; Cephradine; cephradine; Cefradine; 38821-53-3; Cephradin; Anspor; Sefril; Velosef; Cefradina; Cefradinum; Eskacef; Cephradine Dihydrate; Cefradin; Cefradinum [INN-Latin]; Cephradine [USAN:BAN]; Cefradina [INN-Spanish]; SQ 11436; UNII-9YA6SX5S4D; SKF D 39304; VELOSEF '125'; VELOSEF '250'; VELOSEF '500'; Cephradine, Non Stoichiometric Hydrate; CHEBI:3547; SQ-11436; HSDB 3216; 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid; EINECS 254-137-8; (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; BRN 6075388; 9YA6SX5S4D; MFCD00865048; (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cephradine, Non-Stoichiometric Hydrate; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-; 7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid; NCGC00183036-01; DSSTox_CID_2785; DSSTox_RID_76729; DSSTox_GSID_22785; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CED; Cekodin; Megacef; Dexef; Velocef; Megace f; (6R,7R)-7-[(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cephradine (USP); Velosef (TN); Anspor (TN); CAS-38821-53-3; Cephradine (anhydrous); Cefradine (JAN/INN); 75975-70-1; Dihydrate, Cephradine; Infexin; Cephradine,(S); Cefradine [INN]; (6R,7R)-7-((R)-2-amino-2-(cyclohexa-1,4-dienyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; SK-D-39304; SQ-22022; AC1Q6LOA; Epitope ID:116210; SCHEMBL3244; CHEMBL1604; Kelsef; SQ-22022 [Dihydrate]; DivK1c_000739; AC1L1Z38; GTPL4830; DTXSID4022785; HMS502E21; KBio1_000739; NINDS_000739; RDLPVSKMFDYCOR-UEKVPHQBSA-N; BCPP000291; Maxisporin; HY-B1156; SK&F-D39304; ZINC3830515; Tox21_113488; BDBM50370585; s4671; AKOS015961130; Tox21_113488_1; AC-1409; API0001934;